Sherman Matthew L 4
4 · Deciphera Pharmaceuticals, Inc. · Filed Oct 31, 2023
Insider Transaction Report
Form 4
Sherman Matthew L
EVP & Chief Medical Officer
Transactions
- Sale
Common Stock
2023-10-30$12.02/sh−2,360$28,362→ 90,628 total - Award
Common Stock
2023-10-28+8,244→ 92,988 total
Footnotes (2)
- [F1]On February 15, 2023, the Reporting Person was granted restricted stock units ("RSUs"), which vest upon the satisfaction of three performance criteria. On October 28, 2023, the Issuer's Compensation Committee confirmed that performance criteria two had been met, resulting in the vesting of 8,244 RSUs.
- [F2]This sale was to cover tax liabilities in the vesting of RSUs.